Traders Sell Shares of Aetna (AET) on Strength (AET)

Traders sold shares of Aetna Inc. (NYSE:AET) on strength during trading hours on Wednesday. $201.27 million flowed into the stock on the tick-up and $249.49 million flowed out of the stock on the tick-down, for a money net flow of $48.22 million out of the stock. Of all stocks tracked, Aetna had the 0th highest net out-flow for the day. Aetna traded up $0.21 for the day and closed at $178.90

AET has been the topic of a number of research reports. Piper Jaffray Companies restated a “hold” rating and set a $187.00 price objective on shares of Aetna in a research report on Friday, November 3rd. Zacks Investment Research lowered Aetna from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Argus lowered Aetna from a “buy” rating to a “hold” rating and set a $185.00 price objective on the stock. in a research report on Wednesday. BMO Capital Markets boosted their price objective on Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research report on Friday, October 27th. Finally, Cantor Fitzgerald downgraded Aetna from an “overweight” rating to a “neutral” rating in a report on Thursday, October 26th. Twelve equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $175.19.

The company has a market cap of $58,390.00, a price-to-earnings ratio of 17.50, a P/E/G ratio of 1.63 and a beta of 0.61. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The firm’s revenue was down 5.0% compared to the same quarter last year. During the same period in the previous year, the business earned $2.07 EPS. equities analysts forecast that Aetna Inc. will post 9.78 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date is Wednesday, January 10th. Aetna’s dividend payout ratio is 36.97%.

In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Large investors have recently made changes to their positions in the company. FMR LLC raised its stake in Aetna by 73.8% during the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after buying an additional 5,833,567 shares during the period. Janus Henderson Group PLC raised its stake in Aetna by 9,446.2% during the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after buying an additional 4,283,553 shares during the period. Capital World Investors raised its stake in Aetna by 8.9% during the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after buying an additional 1,688,767 shares during the period. Orbimed Advisors LLC raised its stake in Aetna by 57.3% during the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after buying an additional 508,600 shares during the period. Finally, Samlyn Capital LLC acquired a new position in Aetna during the 2nd quarter worth approximately $77,170,000. 88.03% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/12/07/traders-sell-shares-of-aetna-aet-on-strength-aet.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply